Alejandro González Veliz: Key Takeaways from the 2026 ACC Scientific Statement on Antiplatelet Therapy
Alejandro González Veliz, Interventional Cardiologist at Institute of Cardiology and Cardiovascular Surgery, shared a post on LinkedIn about recent article by Dharam J. Kumbhani et al., published in JACC Journals, adding:
“Antiplatelet therapy has entered a new era.
The 2026 ACC Scientific Statement emphasizes that the optimal strategy is no longer defined by fixed durations or universal protocols, but by individualized assessment of ischemic and bleeding risks.
From aspirin in primary prevention to shortened DAPT, P2Y12 inhibitor monotherapy, and long-term secondary prevention, the focus has shifted toward precision medicine.
Understanding when to intensify and when to de-escalate treatment may have a greater impact on outcomes than choosing a specific drug.
Which recommendation do you think will have the greatest impact on your daily practice?
Share your thoughts below.
JACC 2026″
Title: Antiplatelet Therapy in the Management of Atherosclerotic Cardiovascular Disease: 2026 ACC Scientific Statement: A Report of the American College of Cardiology
Authors: Dharam J. Kumbhani, C. Michael Gibson, Scott Kinlay, Eric D. Peterson, Amy W. Pollak, Jacqueline E. Tamis-Holland, and Freek W.A. Verheugt
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 19, 2026, 06:02Thomas Dayspring: Vascular Resilience – What Is It and How Can We Measure It?
-
Oct 19, 2026, 05:53Kevon Dindial: Collaboration for Better Childhood Cancer Outcomes
-
Oct 19, 2026, 05:44Mavis Agnes Kisakye: Raising Awareness about Haemophilia and Other Blood Disorders at Luweero General Hospital
-
Oct 19, 2026, 05:43Mohsen Asadi: Women and Blood Clots – Understanding Risk Across Every Life Stage
-
Oct 19, 2026, 05:39Shivir Moosai: Warm AIHA in a Young Woman
-
Oct 19, 2026, 03:54Jennifer Trowbridge: How Mutant Blood Stem Cells Use Inflammation to Drive Their Own Expansion
-
Oct 19, 2026, 03:39Wyenona Hicks: Catching Up With Old Friends and New Colleagues at AABB 2026
-
Oct 19, 2026, 03:33Developing a Non-Invasive Treatment for Life-Threatening PE – University of Michigan College of Engineering
-
Oct 19, 2026, 03:28Jim Hoffman: How NETs Contribute to Gallstone Formation and Growth